8 Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in blaKPC-3-harboring Klebsiella pneumoniae

9 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

10 Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016

11 Metabolic mechanism of ceftazidime resistance in Vibrio alginolyticus

12 Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

13 In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

14 Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

15 Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015

16 Right and left ventricular function in hospitalized children with respiratory syncytial virus infection

17 Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety

18 Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

19 Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection

20 Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

21 Ceftaroline in complicated skin and skin-structure infections

22 Emerging agents to combat complicated and resistant infections: focus on ceftobiprole

23 Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles

24 Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study

25 Intravascular ultrasound-guided percutaneous coronary intervention in left main coronary bifurcation lesions: a review

26 Cardiovascular prognosis in patients with preserved left ventricular ejection fraction and no significant ischemia

27 Transcatheter left atrial appendage occlusion: patient selection and perspectives

28 Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients

29 A novel porcine model of early left ventricular dysfunction for translational research

30 The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials

31 Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in blaKPC-3-harboring Klebsiella pneumoniae

32 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

33 Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in blaKPC-3-harboring Klebsiella pneumoniae

34 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

35 Preemptive ECMO Cannulation in a Patient with Severe Left Ventricular Systolic Dysfunction Undergoing Cesarean Delivery

36 Antithrombotic Dilemmas after Left Atrial Appendage Occlusion Watchman Device Placement

37 Successful Resolution of a Large Left Atrial and Left Atrial Appendage Thrombus with Rivaroxaban

38 Transient Global Amnesia as the Sole Presentation of an Acute Stroke in the Left Cingulate Gyrus

39 Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016

40 Metabolic mechanism of ceftazidime resistance in Vibrio alginolyticus

41 Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

42 In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

43 Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime–avibactam

44 Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015

45 Case Report: Kryptonite—A Rare Case of Left-Sided Bilothorax in a Sickle Cell Patient

46 Three Rare Structural Anomalies: Right Aberrant Subclavian Artery, Kommerell’s Diverticulum, and Isolated Left Vertebral Artery All Associated with Type B Aortic Dissection

47 Right and left ventricular function in hospitalized children with respiratory syncytial virus infection

48 Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety

49 Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

50 Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection

51 Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

52 Ceftaroline in complicated skin and skin-structure infections

53 Emerging agents to combat complicated and resistant infections: focus on ceftobiprole

54 Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibility profiles

55 Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study

56 Intravascular ultrasound-guided percutaneous coronary intervention in left main coronary bifurcation lesions: a review

57 Cardiovascular prognosis in patients with preserved left ventricular ejection fraction and no significant ischemia

58 Transcatheter left atrial appendage occlusion: patient selection and perspectives

59 Left atrial appendage closure devices for cardiovascular risk reduction in atrial fibrillation patients

60 A novel porcine model of early left ventricular dysfunction for translational research

61 ŞEFTALİ POSASINDAN ULTRASON VE MİKRODALGA DESTEKLİ EKSTRAKSİYON YÖNTEMLERİYLE FENOLİK BİLEŞİKLERİN ELDESİ

62 Review on Design and Simulation of Electricity Theft Detection and Protection System with their techno-economic Study

63 Oral Mucosa-Derived Induced Pluripotent Stem Cells from Patients with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.

64 'Left like stones in the middle of the road': Narratives of aging alone and coping strategies in rural Albania and Bulgaria.

65 Ephemeral alliances: The left and revolutionary nationalism in the magazine política: Quince días de méxico y del mundo (1960-1962)

66 Detection of unexpected ischaemia due to left main disease during tele-rehabilitation using 12-lead electrocardiogram monitoring: a case report.

67 The pathology and aetiology of subcortical clefts in infants.

68 Diabetic cardiomyopathy: acute and reversible left ventricular systolic dysfunction due to cardiotoxicity of hyperglycaemic hyperosmolar state-a case report†.

69 Relationship Between Work Environments, Nurse Outcomes, and Quality of Care in ICUs: Mediating Role of Nursing Care Left Undone

70 Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study

71 Severe thrombocytopenia complicating giant left atrial rhabdomyosarcoma.

72 Biological properties of chitosan derivatives associated with the ceftazidime drug.

73 Rotations, Transformations, Left Quaternions, Right Quaternions?

74 Canonical, squeezed and fermionic coherent states in a right quaternionic Hilbert space with a left multiplication on it

75 Network-based identification of critical regulators as putative drivers of human cleft lip

76 Suicide ideation and suicide plan in Chinese left-behind children: Prevalence and associated factors

77 Left-right and Yin-Yang balance of biophoton emission from hands.

78 International confederation for cleft lip and palate and related craniofacial anomalies task force report: palatoplasty in the speaking individual with unrepaired cleft palate.

79 Home Disposal Kits for Leftover Opioid Medications After Surgery: Do They Work?

80 Airway Management of the Right Anterior Segmentectomy through Uniportal video-assisted thoracoscopic surgery (VATS) after left pneumonectomy by an adapted double-lumen endobronchial tube (DLT): a case report

81 Early Detection of Pump Thrombosis in Patients With Left Ventricular Assist Device.

82 Using a neural network to predict deviations in mean heart dose during the treatment of left-sided deep inspiration breath hold patients.

83 Dynamic Pixel-wise Weighting-based Fully Convolutional Neural Networks for Left Ventricle Segmentation in Short-axis MRI.

84 Orsakir búferlaflutninga fyrir og eftir bankahrun

85 Computational Analysis of the Mature Unilateral Cleft Lip Nasal Deformity on Nasal Patency.

86 Composition of event concepts: Evidence for distinct roles for the left and right anterior temporal lobes.

87 RETRACTED: Peripheral "Right to Right" Extracoporeal Membrane Oxygenation for Right Heart Failure Following Left Ventricular Assist Device Insertion.

88 Characterizing cleft palate toxicants using ToxCast data, chemical structure, and the biomedical literature.

89 Left is "good": Observed action affects the association between horizontal space and affective valence.

90 What's left after the hype? An empirical approach comparing the distributional properties of traditional and virtual currency exchange rates.

91 Socio-Psychological Effects of Emigration on Left Behind Women in Buner, Khyber Pakhtunkhwa, Pakistan

92 Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial.

93 Left-right function of dmrt2 genes is not conserved between zebrafish and mouse.

94 Syndromic Oral Clefts: Challenges of Genetic Assessment in Brazil and Suggestions to Improve Health Policies.

95 Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

96 Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study).

97 Left Noetherian rings with differentially trivial proper quotient rings

98 Evaluation of an in-house self-held respiration monitoring device for deep inspiration breath hold techniques for radiotherapy of patients with cancer of the left breast

99 Evaluation of the Efficiency of Alveolar Opening in Cardiosurgical Patients with Low Left Ventricular Ejection Fraction

100 Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.

101 Multi optimized SVM classifiers for motor imagery left and right hand movement identification.

Keyword Connections

Journals

Research Groups

Bibliographies